Microarray analysis of gene expression during epithelial-mesenchymal transformation

Developmental Dynamics

Volumn 234, Issue 1, 2005, Pages 132-142

  LaGamba, Darnian ^a   Nawshad, Ali ^a   Hay, Elizabeth D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

EMT; Epithelial mesenchymal transformation; LEF 1; Palatogenesis; Smad; TGF

Indexed keywords

BETA CATENIN; BETA1 INTEGRIN; CADHERIN; CASPASE 3; CASPASE 7; CYCLIN D1; DESMOCOLLIN; DESMOGLEIN; F ACTIN; FIBRONECTIN; FILAMIN; FOCAL ADHESION KINASE; GENE PRODUCT; KERATIN; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLAKOGLOBIN; PLAKOPHILIN; PROTEIN FOS; SMAD PROTEIN; SMAD2 PROTEIN; SMAD4 PROTEIN; STROMELYSIN 3; TALIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; VIMENTIN; VINCULIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE; CELL MIGRATION; CELL POLARITY; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; EMBRYO; EPITHELIUM; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENOMICS; IN VITRO STUDY; MESENCHYME; MOUSE; NICK END LABELING; NONHUMAN; PALATE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELLS, CULTURED; EPITHELIUM; GENE EXPRESSION PROFILING; MESODERM; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PALATE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 23944522749     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.20489     Document Type: Article

References (36)

1. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810.
2. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. 2001. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27-36.
3. Birchmeier C, Birchmeier W, Brand-Saberi B. 1996. Epithelial-mesenchymal transitions in cancer progression. Acta Anat 156:217-226.
4. Critchley DR. 2000. Focal adhesions - the cytoskeletal connection. Curr Opin Cell Biol 12:133-139.
5. Cuervo R, Covarrubias L. 2003. Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis. Development 131:15-24.
6. Cui XM, Chai Y, Chen J, Yamamoto T, Ito Y, Bringas P, Shuler F. 2003. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion. Dev Dyn 227:387-394.
7. Derynck R, Feng XH. 1997. TGF-β receptor signaling. Bioch Biophys Acta 1333:F105-F150.
8. Eger A, Stockinger A, Schaffhauser B, Beug H, Foisner R. 2000. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and up-regulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J Cell Biol 148:173-188.
9. Fitchett JE, Hay ED. 1989. Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse. Dev Biol 131:455-474.
10. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285:1028-1032.
11. Griffith CM, Hay ED. 1992. Epithelial-mesenchymal transformation during palatal fusion: carboxyfluorescein traces cells at light and electron microscopic levels. Development 116:1087-1099.
12. Hay ED. 1995. An overview of epitheliomesenchymal transformation. Acta Anat 154:8-20.
13. Hay ED, Zuk A. 1995. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 26:678-690.
14. Hecht A, Kemler R. 2000. Curbing the nuclear activities of beta-catenin. Control over Wnt target gene expression. EMBO Rep 1:24-28.
15. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. 2004. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114:569-581.
16. Kaartinen V, Haataja L, Nagy A, Heisterkamp N, Groffen J. 2002. TGF-β3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: Implications for palatogenesis. Intern J Mol Med 9:563-570.
17. Kim K, Lu Z, Hay ED. 2002. Direct evidence for a role of β-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Intern. 26:463-476.
18. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784-1787.
19. Labbe E, Letamendia A, Attisano L. 2000. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 97:8358-8363.
20. Nawshad A, Hay ED. 2003. TGF-beta3 signaling activates transcription of the LEF-1 gene to induce epithelial mesenchymal transformation during mouse palate development. J Cell Biol 163:1291-1301.
21. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. 2000. Interaction between Wnt and TGF-beta signaling pathways during formation of Spemann's organizer. Nature 403:781-785.
22. Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S. 1998. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A 95:4374-4379.
23. Penheiter SG, Mitchell H, Garamszegi N, Edens M, Dore JJ Jr, Leof EB. 2002. Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling by means of the Smad pathway. Mol Cell Biol 22:4750-4759.
24. Prunier C, Pessah M, Ferrand N, Seo SR, Howe P, Atfi A. 2003. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J Biol Chem 278:26249-26257.
25. Robson CN, Gnanapragasam V, Byrne RL, Collins AT, Neal DE. 1999. Transforming growth factor-β1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. J Endocrinol 160:257-266.
26. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Mullauer L, Ruttkay-Nedecky B. 1995. Apoptosis and multistage carcinogenesis in rat liver. Mutat Res 333:81-87.
27. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
28. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
29. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci 96:5522-5527.
30. Sun D, Vanderburg CR, Odierna GS, Hay ED. 1998a. TGFβ3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro. Development 125:95-105.
31. Sun D, Mcalmon KR, Davies JA, Bernfield M, Hay ED. 1998b. Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int J Dev Biol 42:733-736.
32. Vanderburg CR, Hay ED. 1996. E-cadherin transforms embryonic corneal fibroblasts to stratified epithelium with desmosomes. Acta Anat 157:87-104.
33. Whitmarsh AJ, Davis RJ. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607.
34. Wu G, Chen YG, Ozdamar B, Gyuricza CA, Chong PA, Wrana JL, Massague J, Shi Y. 2000. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 287:92-97.
35. Yue J, Mulder K. 2001. Transforming growth factor-β signal transduction in epithelial cells. Pharmacol Ther 91:1-34.
36. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. 2004. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 5:1155-1165.